Newsroom
Sorted by: Latest
-
Computershare Trustees (Jersey) Limited UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Computershare Trustees (Jersey) Limited as trustee of the Schroders Employee Benefit Trust (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. Fo...
-
Xtrackers II UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Xtrackers II Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-124.284 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 18 June 2026 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”, and t...
-
Xtrackers UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Xtrackers Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-119.899 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 18 June 2026 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”, and toge...
-
Pheno Therapeutics Granted FDA IND Clearance for Lead Multiple Sclerosis Therapeutic Candidate PTD802
EDINBURGH, Scotland--(BUSINESS WIRE)--Pheno Therapeutics Limited. (Pheno), a clinical stage biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, today announced that the US Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for PTD802, the Company’s lead therapeutic candidate. The clearance allows Pheno to proceed with a first-in-human clinical trial of PTD802 in the U...
-
Navan Invests in European Footprint with New Partnerships
PALO ALTO, Calif.--(BUSINESS WIRE)--Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced new integrations with European travel suppliers. Navan will add to its platform a direct New Distribution Capability (NDC) connection with Italy’s national air carrier, ITA Airways; overnight rail services in the UK with Caledonian Sleeper; and mobile-first car rental bookings in France with Virtuo. “We’re seeing incredible momentum across Europe, bookings to and...
-
Northern Trust Appointed to Support TirNua Capital Partners’ Inaugural Infrastructure Fund
DUBLIN--(BUSINESS WIRE)--Northern Trust (Nasdaq: NTRS) today announced it has been appointed by TirNua Capital Partners (“TirNua”) to provide fund administration, depositary and banking services for the firm’s inaugural infrastructure fund focused on supporting the transition to a low carbon economy. The fund has secured €340 million in commitments at first close (source: www.tirnua.com).Headquartered in Dublin, TirNua is a private markets investment manager focused on investing in critical infr...
-
AM Best to Join Panel Discussion at 2026 Azerbaijan International Insurance Forum
LONDON--(BUSINESS WIRE)--AM Best will speak on a panel at the 2026 Azerbaijan International Insurance Forum, scheduled for 24-25 June 2026 in Baku, Azerbaijan.Vasilis Katsipis, general manager, MENA, South and Central Asia, AM Best, will join a panel discussion, titled, “Absorbing the Shock: Reinsurance, Nat Cat Risk and Market Resilience,” during which he will offer AM Best’s views on the role of credit ratings in measuring insurer resilience. The session is scheduled for 24 June 2026 at 2 p.m....
-
Over 50% of Brands Have Adopted Agentic AI, Yet High-Value Customer Journeys Remain in Manual Limbo, Infobip Report Finds
LONDON--(BUSINESS WIRE)--A study from global AI-first cloud communications platform Infobip has revealed a stark contradiction in the race for AI supremacy....
-
Reply gibt die Finalisten der zweiten Ausgabe des „AI Music Contest“ bekannt - internationaler Wettbewerb verbindet KI und Live-Performance
TURIN, Italien--(BUSINESS WIRE)--Beim „Reply AI Music Contest“ verschmelzen Musik und Künstliche Intelligenz (KI), um neue Formen des Zusammenspiels von Technologie und Live-Performance zu auszuloten. Der von Reply gemeinsam mit dem Kappa FuturFestival – einem der führenden Festivals für elektronische Musik und kulturelle Innovation in Europa – veranstaltete Wettbewerb stellt die fünf Finalisten der diesjährigen Ausgabe vor. Eine internationale Fachjury aus Vertretern der Musik- und Kreativbran...
-
Finalists Announced for the Second Edition of the Reply AI Music Contest, the International Competition Exploring the Relationship Between AI and Live Performance
TURIN, Italy--(BUSINESS WIRE)--Music and artificial intelligence come together at the Reply AI Music Contest to explore the relationship between AI and live performance. The competition, created by Reply and organized in collaboration with Kappa FuturFestival — one of Europe’s leading festivals dedicated to electronic music and cultural innovation — announces the five finalists selected by an international jury of professionals from music and creative industries: Agoria, Max Cooper, Fleur Shore...